Arthur C. Theodore - Concepedia

Author

Arthur C. Theodore

Also Known As

A C Theodore, A Theodore, A Thêodore, Arthur C. Theodore, Arthur Theodore, Dennis J. Beer, Gregory Viglianti, H Kornfeld, John Bernardo, William W Cruikshank

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

Boston University University of California, Los Angeles Medical University of South Carolina Johns Hopkins University University of Illinois Chicago

About

Arthur C. Theodore is an author at Boston University specializing in medicine, autoimmune disease, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.4K
2	Immunology	3	3	107
3	Allergy	2	2	137
4	Cell Biology	2	2	50
5	Pathology	2	2	1.1K

Arthur C. Theodore

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline Ganesh Raghu, Bram Rochwerg, Yuan Zhang, American Journal of Respiratory and Critical Care Medicine	2015	1.9K
Cyclophosphamide versus Placebo in Scleroderma Lung Disease Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, New England Journal of Medicine	2006	1.6K
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial Donald P. Tashkin, Michael D. Roth, Philip J. Clements, The Lancet Respiratory Medicine Sls IiMycophenolate MofetilInflammatory Lung DiseaseAdvanced Lung DiseaseSystemic Scleroderma	2016	1K
Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, American Journal of Respiratory and Critical Care Medicine	2007	463
Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay* John Marshall, Christine Finn, Arthur C. Theodore Critical Care Medicine	2008	210
Lymphokine activation of T4+ T lymphocytes and monocytes. William W. Cruikshank, Jeffrey S. Berman, Arthur C. Theodore, The Journal of Immunology	1987	195
Propylene Glycol Toxicity: A Severe Iatrogenic Illness in ICU Patients Receiving IV Benzodiazepines Kevin C. Wilson, Christine C. Reardon, Arthur C. Theodore, CHEST Journal Icu PatientsMedicinePropylene Glycol ToxicityIv BenzodiazepinesPharmacotherapy	2005	169
Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung Disease Charlie Strange, Marcy B. Bolster, Michael D. Roth, American Journal of Respiratory and Critical Care Medicine	2007	146
Correlation of the degree of dyspnea with health‐related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: Results from the scleroderma lung study Dinesh Khanna, Philip J. Clements, Daniel E. Fürst, Arthritis & Rheumatism	2005	134
IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation William W. Cruikshank, Kaiser G. Lim, Arthur C. Theodore, The Journal of Immunology	1996	133

Page 1